Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1989-7-5
pubmed:abstractText
Thirty-one patients affected by advanced ALL entered this study. Twenty (1 in I CR, 9 in II CR, 6 in III CR and 4 extramedullary relapses) were treated with the BMVC conditioning regimen. Eleven (9 in II CR, 2 in III CR) received the Busulfan plus Cytoxan conditioning regimen. Asta-Z 7654-purged marrow was reinfused at day 0. Both protocols were well tolerated. Two patients treated with the BMVC regimen died in aplasia from sepsis; 1 patient died in CR 5 months after transplantation, 13 relapsed after a median time of 4 months (range 1-31). Four patients are in CCR with a median follow-up of 16 months (range 11-24). In the BU + CY treated group no toxic deaths were observed. Four patients relapsed after a median of 3 months (range 2-7) and 7 are in CCR with a median follow-up of 5 months (range 2-28).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0390-6078
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
67-70
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:2498186-Adolescent, pubmed-meshheading:2498186-Adult, pubmed-meshheading:2498186-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:2498186-Bone Marrow Transplantation, pubmed-meshheading:2498186-Busulfan, pubmed-meshheading:2498186-Carmustine, pubmed-meshheading:2498186-Child, pubmed-meshheading:2498186-Combined Modality Therapy, pubmed-meshheading:2498186-Cyclophosphamide, pubmed-meshheading:2498186-Cytarabine, pubmed-meshheading:2498186-Drug Resistance, pubmed-meshheading:2498186-Etoposide, pubmed-meshheading:2498186-Female, pubmed-meshheading:2498186-Humans, pubmed-meshheading:2498186-Male, pubmed-meshheading:2498186-Mitoxantrone, pubmed-meshheading:2498186-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:2498186-Preoperative Care, pubmed-meshheading:2498186-Transplantation, Autologous
pubmed:articleTitle
Results of two different conditioning regimens followed by ABMT in refractory acute lymphoblastic leukemia.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't